Henk Reesink

General Secretary

CURRICULUM VITAE

Borne : April 23rd, 1942, Gorssel, The Netherlands.

Nationality : Dutch.

Educated and living in : The Netherlands.

Marital status : Married, 2 children

EDUCATION

1955 – 1961 : Gymnasium-B, certificate 1961.

1961 – 1969 : Medical School Medical University of Amsterdam. Medical Doctor, 1969.

1969 – 1973 : Specialisation in immuno-hematology and transfusion medicine at the Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands under the supervision of Prof. Dr. J.J. van Loghem and  Prof. Dr. C.P. Engelfriet

1979 – 1982 : Specialisation in internal medicine University Hospital of Amsterdam (Wilhelmina Gasthuis), The Netherlands, under the supervision of Prof.Dr. M. Koster and Prof.Dr. J. Vreeken. Registration 1983.

1980 : PhD Thesis: Studies on transmission and prevention of Hepatitis B. promoters: prof J.J. van Loghem and Prof. C.P. Engelfriet

WORKING EXPERIENCE – PAST POSITIONS

1973 – 1979 : Medical Director of the Red Cross Blood Bank, Amsterdam, The Netherlands.

1973 – 1979 : Research fellow at the Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands.

1979 – 1982 : Trainee internal medicine at the University Hospital of Amsterdam (Wilhelmina Gasthuis) under supervision of Prof.Dr. M. Koster and Prof.Dr. J. Vreeken.

1979 – 1982 : Co-ordinator of clinical trials with the HB-vaccine in the Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands.

1979 – 1983 : Medical advisor Red Cross Blood Bank Amsterdam

1983 – 1998 : Medical Director of the Red Cross Blood Bank Amsterdam, The Netherlands.

1983 – 1994 : Research Fellow, Department of Viral Diagnostics, Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands

1983 – 1994 : Internist/Hepatologist at the Academic Medical Center of the University of Amsterdam, Department of Gastroenterology and Hepatology. Special interest: Viral Hepatitis.

1983 – 2005 : Internist at the Onze Lieve Vrouwe Gasthuis Hospital, Amsterdam, The Netherlands.

1986 – 1989 : Project Leader of the ‘Development anti-AIDS immunoglobulin programme’ at the Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands.

1989 – 1995 : Project Leader ‘Hepatitis C Virus research programme’ at the Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam and at the Red Cross Blood Bank Amsterdam.

1999 – 2007 : Consultant Research and Development, with special focus on blood transmissible infectious agents, Sanquin Blood Bank North-West Region and Sanquin Diagnostic Services, Amsterdam, The Netherlands

2000 – 2005 : Head Infectious Disease Screening Laboratory, Sanquin Diagnostic Services

Jan 2012 – jun 2012 : Medical Director Nationaal Hepatitis Centrum, Amersfoort, The Netherlands

PRESENT POSITIONS

1994 – present : Associate professor at the Academic Medical Center of the University of Amsterdam, Head of viral hepatitis research, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands. Special interest: Viral Hepatitis.

2009 – present : Director Medical Advisory Bureau on Viral hepatitis and Blood Transfusion

PAST COMMITTEE FUNCTIONS

1972 – 2000 : Member of the Medical Advisory Committee of the Central Medical Blood Transfusion Committee of The Netherlands Red Cross (renamed 1989: Blood Transfusion Council of The Netherlands Red Cross; renamed 1998 Sanquin Blood Supply Foundation).

1988 – 1998 : Permanent Member of the Standardization Committee of the Federation of The Netherlands Red Cross Blood Banks.

1989 – 1999 : Inspector and Regional Coordinator for the Internal Inspection and Certification Committee of the Federation of The Netherlands Red Cross Blood Banks. (The Federation is renamed in 1998: Sanquin Blood Supply Foundation)

1990 – 1997 : Member of the ad hoc Expert Committee of the EEC on Liver Disease (Eurohep).

1990 – 2013  : Section-Editor Vox Sanguinis. International Journal on Transfusion Medicine and Immuno Hematology.

1991 – 1994 : Chairman of the Board of Medical Specialist of the Ziekenverpleging Prinsengracht Hospital, Amsterdam, The Netherlands.

1992 – 1994 : Chairman Scientific Committee XXIIIrd Congress of The International Society of Blood Transfusion 1994, Amsterdam.

1992 – 1994 : Member of the Board of Foundation Transfusion Medicine, Amsterdam, The Netherlands

1994 – 1997 : Member of the Board of Medical Specialists of the Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.

1994 – 1997 : Chairman of the Working Party of the Blood Transfusion Council of The Netherlands Red Cross for the development of guidelines for ‘Donor selection and physical investigation’.

1994 – 1999 : Expert on Hepatitis C look-back for Blood Transfusion Organizations in Australia, Canada and the UK (personal title).

1995 – 1997 : Member of the No Fault Compensation Committee of the Blood Transfusion Council of The Netherlands Red Cross

1995 – 1999 : Member of the Ethical Advisory Committee of the Federation of The Netherlands Red Cross Blood Banks. (The Federation is renamed in 1998: Sanquin Blood Supply Foundation)

1995 – 1996 : Member of the Scientific Committee XXIVth Congress of the International Society of Blood Transfusion (ISBT) 1996, Tokyo, Japan.

1995 – 1998 : Member of the Working Party on Infectious Diseases (Blood Transfusion Council of The Netherlands Red Cross)

1996 – 1998 : Member of the Scientific Committee XXVth Congress of the International Society of Blood Transfusion (ISBT) 1998 , Oslo, Norway

1996 – 1997 : Member of Committee on Lookback of HCV. National Health Council, The Netherlands

1996 – 1998 : Expert for selection of donors and laboratory screening of blood donations. European Commission, appointed by the Ministry of Health, The Netherlands.

1996 – 2000 : Adviser Pharmacopeia Committee United States (USP) on blood transfusion.

1997 – 1998 : Chairman Working Party on implementation of HCV nucleic acid amplification tests (NAT) in The Netherlands. (Sanquin Blood Supply Foundation)

1999 – 2000 : Editorial Board Transfusion Medicine Reviews

1999 – 2001 : Chairman project group on implementation of HCV- and HIV–NAT in The Netherlands (Sanquin Blood Supply Foundation)

1999 – 2013 : International Member of Safety Advisory Committee of

Héma-Quebec (Montreal, Canada)

2000 – 2008 : Editorial Board Transfusion. The journal of the American Association of Blood Banks.

2002 – 2007 : Chairman of the Working Party on laboratory investigation of infectious agents (Sanquin Blood Supply Foundation).

2006 – 2011 : Member of the International Activities Working Group (IAWG) of American Association of Blood Banks

2009 – 2010 : Member of the Scientific Committee XXXIth Congress of the International Society of Bloody Transfusion (ISBT).

2009 – 2012 : Chairman Medical Advisory Board Nationaal hepatitis Centrum

2012 – 2013 : Key expert and chairman of the European Union’s IPA Programme  (TAIB – 2009): strengthening of the Blood Safety System (Macedonia)

PRESENT COMMITTEE FUNCTIONS

1987 – present : Chairman of the Foundation for Blood Transfusion and other Clinical Research, Amsterdam, The Netherlands.

1990 – present : Member of the Working Party on Transfusion Transmitted Diseases (ISBT)

1994 – present : Secretary General of the Board of Foundation Transfusion Medicine, Amsterdam, The Netherlands

2005-present : Advisory Board of the following companies: AbbVie, BMS, Gilead, GlaxoSmithKline, Janssen-Cilag, Merck/MSD, PRA Health Services, Roche, Santaris, Regulus, R-Pharm, Korean Green Cross, Replicor, Alnylam, ENYO.

2013 – present : Chairman Viral Hepatitis Foundation

EXPERIENCE CLINICAL TRIALS

See publications

CO-PROMOTOR AND SUPERVISION OF THE PREPARATION OF THE PhD THESES OF:

– dr. R.N.I. Pietersz (1988)

Thesis: Leucocyte-poor platelet concentrates. A new method for routine preparation.

– dr. P.N. Lelie (1989)

Thesis: Studies with a heat-inactivated Hepatitis-B vaccine.

– dr. C.L. van der Poel  (1991)

Thesis: Hepatitis C Virus: Studies on transmission and epidemiology.

– dr. D. Bresters  (1993)

Thesis: Detection of Hepatitis C Virus infection

– dr. H.L. Zaaijer  (1995)

Thesis: Confirmatory testing of blood-borne viral infections.

– dr. A. Nurman (1995)

Thesis: Portal Hypertensive Gastropathy and Gastric Mucosal Blood Flow in patients with cirrhosis of the liver.

– dr. H. Vrielink (1996)

Thesis: Laboratory Diagnosis of Viruses transmitted by Blood Transfusion

– dr. M. Damen (1999)

Thesis: Chronic hepatitis C: new diagnostics tools and therapeutic strategies

– dr. P.F. van der Meer (2000)

Thesis: New developments in blood component preparation

– dr. R. Sentjens (2003)

Thesis: New developments in hepatitis B, C and G virus

– dr. Chr. Weegink (2004)

Thesis: Hepatitis C infection: The quest for new treatment strategies

– dr. M. Dijkstra-Tiekstra (2004)

Thesis: Biomedical excellence for safer transfusion of platelet concentrates: Best of PCs

– dr. T. Mohammadi (2006)

Thesis: Bacterial contamination of platelet concentrates: Molecular tools and applications

– dr. M. Koppelman (2006)

Thesis: Viral safety of blood donations: Molecular detection of blood transmittable viruses

– dr. Doug Hun Lee (2007)

Thesis: Nucleic acid amplification testing for screening of individual blood units

– dr. H.C. Gelderblom (2008)

Thesis: Towards optimal treatment for chronic hepatitis C infection.

– dr. R.B. Takkenberg (2011)

Thesis: Response and Markers of Response in Chronic Hepatitis B Patients Treated with a Combination of Peginterferon-alfa 2a and Adefovir Dipivoxil- dr. J. de Bruijne (2012)

Thesis: Direct acting antiviral therapy for chronic Hepatitis C

– dr. L. Jansen (2016)

Thesis: Virus-Host Interplay in Chronic Hepatitis B: predicting response to immune modulating antiviral therapy

– dr. A. de Niet (2016)

Thesis: New Treatment Strategies for Chronic Hepatitis B. Viral, Genetic and Immunological Factors Predicting Treatment Outcome

– dr. M. van der Ree (29 June 2017)

Thesis: microRNA’s in chronic hepatitis B and C virus infection’

– dr. F. Stelma (30 November 2017)

    Thesis: Immune responses in hepatitis B and C virus infection

– drs. R. Erken, thesis in preparation (2017-2021)

– drs. J. Helder, thesis in preparation (2017-2021)

– V. Lukachof, thesis in preparation (2017-2021)

COURSES

BROK re-registration: 13 January 2015

LECTURES

Numerous lectures on various aspects of transfusion transmitted diseases including viral hepatitis with focus on direct anti-viral medicines were held in The Netherlands and abroad.

EDITOR OF THE FOLLOWING BOOKS

Hepatitis C virus. In: Current studies in hematology and blood transfusion, Nr. 61. Editor: H.W. Reesink. Karger, Basel, 1994

State-of-the-art lectures. Guest editors H.W. Reesink, R.N.I. Pietersz, P.F.W. Strengers, W.G. van Aken. Vox Sanguinis: International Journal of Transfusion Medicine. July 1994; 67(S3).94

Plenary and Educational Lectures. Editors C.P. Engelfriet, H.W. Reesink. Vox Sanguinis: International Journal of Transfusion Medicine. January 1996; 70(S3).96

Hepatitis C virus. 2nd, revised and enlarged edition. In: Current studies in hematology and blood transfusion. Nr. 62. Editor: H.W. Reesink. Karger, Basel, 1998

Various chapters in books were (co-)authored

PUBLICATIONS

PubMed: 382

Web of Knowledge: 668

Hirsch factor

71

Citations: 28,000

I10-index : 309

AWARDS

APASL Award, 2016

The Asian Pacific Association for the study of the liver (APASL) has given the award on the lecture on modern hepatology

ISBT Award, 2013

The ISBT Award is given to ‘Persons who have contributed significantly to blood transfusion and transfusion medicine, mainly in educational aspects’.

GRANTS

From period 2005-2018: €300,000-900,000 per year

H.W. Reesink, MD PhD, Associate Professor

Academic Medical Center, department Gastroentelology and Hepatology